Aptevo Therapeutics Inc.APVONASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank91
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-24.60M
↑ 47% vs avg
Percentile
P91
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-46.56M
Historical baseline
PeriodValueYoY Change
2024$-24.60M+14.8%
2023$-28.88M-0.8%
2022$-28.64M-33.8%
2021$-21.40M+22.2%
2020$-27.49M+32.9%
2019$-40.96M+20.7%
2018$-51.66M+4.2%
2017$-53.95M+57.5%
2016$-126.94M-107.8%
2015$-61.10M-